Company: HUM
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001193125-25-048976
Chunk: 40

Company: HUMANA INC
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 40
---
 former Chief Executive Officer is discussed under “Executive Compensation” in this proxy statement. |

| (2) | Beginning on July 1, 2024, when Mr. Rechtin was elected to our Board, Mr. Rechtin served as President and Chief Executive Officer of the Company, and therefore, as an employee director, did not earn compensation in connection with his service on our Board. Mr. Rechtin’s compensation as our Chief Executive Officer is discussed under “Executive Compensation” in this proxy statement. |

| (3) | Mr. McDonald did not stand for re-election at the April 18, 2024 Annual Meeting of Stockholders. Compensation disclosed represents amount earned for service during 2024 prior to his departure from our Board. |

| (4) | Under the Humana Inc. Deferred Compensation Plan for Non-Employee Directors, which we refer to as the Deferred Compensation Plan, non-employee directors may make an irrevocable election each year to defer compensation paid to them by the Company in the form of cash or stock for services rendered as Board members. For 2024, Mmes. Katz and Klevorn, Drs. Bono, Feinberg, and Frederick, and Messrs. D’Amelio, Hilzinger, McDonald and B. Smith each deferred their stock compensation. Refer to footnote 1(c) to the section titled “Stock Ownership Information — Security Ownership of Directors and Executive Officers” for a disclosure of the number of Shares of our common stock that have been deferred by each director. A director electing to defer cash can choose any of the investment options offered in the Deferred Compensation Plan using Charles Schwab’s Retirement Plan Services (other than the Humana Common Stock Fund) or can invest in stock units that have a value relative to that of our common stock. For 2024, Ms. Katz, Dr. Feinberg, and Messrs. Hilzinger, McDonald and B. Smith each elected to defer a portion or all of their cash compensation under the Deferred Compensation Plan. |

| (5) | On January 2, 2024, when the fair market value of our common stock was $464.85, each director in office at that time, other than Mr. Broussard, was granted a restricted stock unit award of 430 Shares, representing the annual grant of approximately $200,000 in common stock. The amount shown in this column is the grant-date fair market value times the number of Shares awarded